Northwestern Mutual Investment Management Company’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$350K Sell
1,544
-30
-2% -$5.34K ﹤0.01% 847
2026
Q1
$272K Buy
1,574
+2
+0.1% +$371 ﹤0.01% 854
2025
Q4
$314K Buy
1,572
+4
+0.3% +$726 ﹤0.01% 847
2025
Q3
$245K Buy
1,568
+1
+0.1% +$159 ﹤0.01% 861
2025
Q2
$238K Sell
1,567
-60
-4% -$8K ﹤0.01% 862
2025
Q1
$245K Buy
1,627
+3
+0.2% +$503 ﹤0.01% 863
2024
Q4
$300K Sell
1,624
-13
-0.8% -$2.5K 0.01% 841
2024
Q3
$322K Sell
1,637
-3
-0.2% -$623 0.01% 838
2024
Q2
$339K Buy
1,640
+12
+0.7% +$2.72K 0.01% 825
2024
Q1
$441K Buy
1,628
+4
+0.2% +$955 0.01% 795
2023
Q4
$384K Buy
1,624
+5
+0.3% +$983 0.01% 811
2023
Q3
$317K Buy
1,619
+5
+0.3% +$1.03K 0.01% 821
2023
Q2
$339K Buy
1,614
+14
+0.9% +$2.79K 0.01% 826
2023
Q1
$323K Buy
1,600
+6
+0.4% +$1.36K 0.01% 828
2022
Q4
$347K Sell
1,594
-296
-16% -$64.6K 0.01% 694
2022
Q3
$372K Sell
1,890
-141
-7% -$30.4K 0.01% 759
2022
Q2
$435K Buy
2,031
+23
+1% +$5.62K 0.01% 763
2022
Q1
$570K Sell
2,008
-262
-12% -$80.8K 0.01% 738
2021
Q4
$855K Sell
2,270
-19
-0.8% -$7.38K 0.02% 593
2021
Q3
$945K Buy
2,289
+7
+0.3% +$2.91K 0.02% 509
2021
Q2
$844K Sell
2,282
-6,019
-73% -$2.01M 0.01% 570
2021
Q1
$2.41M Sell
8,301
-8,802
-51% -$2.45M 0.04% 159
2020
Q4
$4.27M Sell
17,103
-116
-0.7% -$27.6K 0.06% 129
2020
Q3
$3M Hold
17,219
0.04% 157
2020
Q2
$3M Buy
17,219
+256
+2% +$40.9K 0.04% 154
2020
Q1
$2.14M Buy
16,963
+3,014
+22% +$452K 0.03% 191
2019
Q4
$2.13M Buy
13,949
+32
+0.2% +$4.43K 0.04% 204
2019
Q3
$1.84M Buy
13,917
+13
+0.1% +$1.74K 0.04% 229
2019
Q2
$1.97M Buy
13,904
+5,324
+62% +$722K 0.05% 199
2019
Q1
$1.25M Sell
8,580
-512
-6% -$67.3K 0.02% 511
2018
Q4
$1.03M Buy
9,092
+39
+0.4% +$4.88K 0.02% 557
2018
Q3
$1.22M Sell
9,053
-364
-4% -$44.9K 0.02% 563
2018
Q2
$1.06M Sell
9,417
-288
-3% -$31.1K 0.02% 622
2018
Q1
$1.04M Buy
9,705
+3,502
+56% +$377K 0.02% 630
2017
Q4
$679K Sell
6,203
-23
-0.4% -$2.5K 0.01% 619
2017
Q3
$673K Sell
6,226
-1,974
-24% -$203K 0.01% 610
2017
Q2
$829K Buy
8,200
+36
+0.4% +$3.31K 0.01% 622
2017
Q1
$734K Buy
8,164
+7
+0.1% +$595 0.01% 656
2016
Q4
$621K Buy
8,157
+13
+0.2% +$987 0.01% 672
2016
Q3
$679K Hold
8,144
0.01% 612
2016
Q2
$671K Buy
8,144
+84
+1% +$6.92K 0.01% 444
2016
Q1
$612K Buy
8,060
+2,469
+44% +$183K 0.01% 464
2015
Q4
$449K Buy
5,591
+21
+0.4% +$1.51K 0.01% 564
2015
Q3
$354K Hold
5,570
0.01% 631
2015
Q2
$392K Buy
5,570
+3,040
+120% +$225K 0.01% 645
2015
Q1
$201K Buy
+2,530
New +$187K ﹤0.01% 761

Other funds holding CRL

Northwestern Mutual Investment Management Company's CRL Position: Q2 2026 in Review

Northwestern Mutual Investment Management Company reduced its Charles River Laboratories (CRL) stake by 1.9% in Q2 2026, selling an estimated $5.34K and leaving 1,544 shares worth $350K. The position accounts for ﹤0.01% of the portfolio, ranked #847.

Northwestern Mutual Investment Management Company first reported a position in CRL in Q1 2015 and has held it in 46 quarters since. The position peaked at $4.27M in Q4 2020. 367 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Northwestern Mutual Investment Management Company held 1,544 shares of Charles River Laboratories worth $350K as of Q2 2026.
  • Northwestern Mutual Investment Management Company sold 30 Charles River Laboratories shares in Q2 2026, an estimated $5.34K.
  • Charles River Laboratories made up ﹤0.01% of Northwestern Mutual Investment Management Company's portfolio in Q2 2026, its #847 holding.
  • Northwestern Mutual Investment Management Company first reported a position in Charles River Laboratories in Q1 2015 and has held it in 46 quarters since.
  • Northwestern Mutual Investment Management Company's Charles River Laboratories position peaked at $4.27M in Q4 2020.
  • 367 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Northwestern Mutual Investment Management Company's 13F filing for Q2 2026, filed 12 Aug 2026.